Migraine headaches are a population problem, affecting both men and women. Chronic migraines, although occurring at a much lower rate, are the cause of significant overuse of painkillers due to a lack of effective preventive measures. Recent reports indicate the high efficacy of erenumab as a treatment for chronic migraine pain, as up to now, it has only been associated with the elimination of episodic migraine pain.